Bill > SF850

This bill modifies the existing Minnesota statute governing optometry practice by expanding the scope of drugs that optometrists can prescribe and administer. Specifically, the bill removes previous restrictions on intravenous, intramuscular, and injection-based drug administration, while now permitting sub-Tenon, retrobulbar, and intravitreal injections. The bill eliminates the previous prohibition on prescribing oral antivirals for more than ten days and adjusts limitations on oral steroids, now allowing their prescription for up to 14 days without physician consultation. The bill also removes the previous seven-day limit on prescribing oral carbonic anhydrase inhibitors. These changes expand the clinical capabilities of optometrists by giving them more flexibility in drug prescription and administration, potentially improving patient care by allowing optometrists to provide more comprehensive treatment for eye-related conditions. The modifications align with the evolving scope of optometric practice and potentially reduce the need for patients to seek multiple healthcare providers for eye treatment.

Health and Social Services

https://www.revisor.mn.gov/bills/bill.php?b=Senate&f=SF0850&ssn=0&y=2025